Barbara Feder Ostrov, Senior Correspondent for California Healthline, has reported on medicine and health policy for more than 15 years. She covered the medical beat for the San Jose Mercury News for eight years and edited the website of the Center for Health Journalism at the USC Annenberg School of Journalism. She previously worked at The Palm Beach Post and the Miami Herald. Her work also has been published in The Boston Globe, Ms. Magazine, Atlantic.com, PBS NewsHour, NPR, CNN.com and EverydayHealth.com. She has won awards from the Society for Women’s Health Research, the California Newspaper Publishers Association and the Florida Press Club. She is based in San Jose, California.
Barbara Feder Ostrov
Kaiser Health News
From this contributor
How the college admissions cheating scandal hurts students with disabilities
In the wake of this week's college admissions cheating scandal, families and advocates are worried about a backlash that could make it harder for students with legitimate disabilities to get the accommodations the need.
How the college admissions cheating scandal hurts students with disabilities
By
Barbara Feder Ostrov, Ana B. Ibarra, Kaiser Health News
15 March 2019 | 5 min read
Study of birth defects, folic acid in foods finds more questions than answers
Fortifying cereal and bread products with folic acid has not led to as dramatic a decline in congenital defects as expected.
Study of birth defects, folic acid in foods finds more questions than answers
By
Barbara Feder Ostrov, Kaiser Health News
23 May 2016 | 6 min read
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
By
Chand Chandrasekaran
20 April 2026 | 6 min read
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read